Detalhe da pesquisa
1.
Regulation of neurexin 1beta tertiary structure and ligand binding through alternative splicing.
Structure
; 16(3): 422-31, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18334217
2.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
Bioorg Med Chem Lett
; 19(3): 981-5, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095443
3.
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
Bioorg Med Chem Lett
; 19(3): 976-80, 2009 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19095442
4.
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
Bioorg Med Chem Lett
; 19(4): 1177-82, 2009 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19138846
5.
Crystal structure of the second LNS/LG domain from neurexin 1alpha: Ca2+ binding and the effects of alternative splicing.
J Biol Chem
; 281(32): 22896-905, 2006 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-16772286